Sign in
CompletedNo phase

Blood Flow Regulation in Individuals With Down Syndrome - Training Study

Key facts

Who runs it
University of Nevada, Las Vegas
Where
Las Vegas, United StatesSee the site
Trial code
Status
Completed
People taking part
60 people enrolled
Started
9 Sept 2021
Ended
31 Aug 2024
Type of study
Interventional, 3 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Combined exercise intervention
  • Usual care / Sham intervention
Record updated
4 February 2026

Who can take part

Age
18 years to 35 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • generally healthy
  • sedentary (defined as being involved in less than 30 minutes of moderately-intense physical activity per day)
  • additionally for the participants with Down syndrome:
  • diagnosis of Down syndrome trisomy 21 and
  • normal thyroid function or stable thyroid function (and medications) for at least 6 mo

Who cannot take part

  • anti-inflammatory medication including NSAIDS
  • congenital heart disease
  • atherosclerotic or other vascular disease
  • asthma or other pulmonary disease
  • hypertension (defined BP >140/90 mmHg)
  • history of pre-syncope or syncope
  • medications affecting heart rate, blood pressure or arterial function
  • diabetes (defined as Hba1c of >7.5% or use of glucose lowering medication)
  • blood pressure below 90/60 mmHg
  • severe obesity (defined as BMI >40)
  • current smoking and
  • pregnancy

Where in United States

  • University of Nevada Las VegasLas Vegas, United States

About the trial

What the trial wants to find out

Work capacity is an important predictor of declining health or physical function, and of mortality, and is commonly measured as peak oxygen consumption. Peak oxygen consumption is very low in individuals with Down syndrome, the most prevalent genetic cause of intellectual disability. Previous research suggests individuals with Down syndrome may experience a double disadvantage when they are exercising: they may not be able to increase cardiac output sufficiently and they may not be able to allocate adequate blood flow to the working muscles. The aim of this research proposal is therefore to investigate the responses in central and peripheral blood flow regulation and cardiac autonomic function to exercise training in individuals with DS. Additionally the effects of exercise on gait, balance and attitude towards exercise in individuals with DS are investigated.

The 3 groups in the trial

  • Combined exercise intervention Down syndromeTreatment being tested

    The exercise intervention will last 12 weeks and will consist of a supervised combined aerobic and resistance training program with a frequency of 3 days/week.In the exercise sessions, the participant will work with the trainer on their strength, balance and aerobic endurance. Each session consists of 10 min of strength exercises (Foundational Exercise), 10 min of Hip Strengthening, 10 min of Vestibular and Balance Exercise, and 20 min of Aerobic Exercise, and starts with a warming up and ends with stretching/cooling down. Each new exercise will be introduced in easy steps and practiced until the participant is comfortable executing it.

    Treatment: Combined exercise intervention

  • Usual care Down SyndromeSham treatment, for comparison

    The control condition consists of usual activities.

    Treatment: Usual care / Sham intervention

  • Reference group without Down syndromeNo study treatment, for comparison

    This reference group of age- and sex-matched inactive individuals without Down syndrome will undergo the same baseline testing as the other groups but without intervention or post-intervention measures.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Effects of Exercise Training on Central and Peripheral Blood Flow Regulation in Individuals With Down Syndrome
Record updated
4 February 2026